# Capturing the molecular complexity of tau pathology-associated proteomes involved in the etiology of Alzheimer's disease and related dementias

> **NIH NIH RF1** · MAYO CLINIC  JACKSONVILLE · 2023 · $304,220

## Abstract

Contact PD/PI: Rossoll, Wilfried
PROJECT SUMMARY/ABSTRACT
 The goal of this project is to capture the molecular complexity of pathological tau-associated proteomes in
the brain of Alzheimer’s disease (AD) and related tauopathy patients, in order to gain a thorough mechanistic
understanding of their role in the pathophysiology of these dementias.
 Recent studies suggest a correlation of characteristic temporal and topographic patterns of microtubule-
associated protein tau (MAPT) aggregates with the observed clinical phenotype and progression of AD.
Although neurofibrillary tangles (NFTs) and other forms of phospho-tau aggregates are believed to play a
pivotal role in the disease process, we have a poor understanding of the composition and molecular
environment of these insoluble aggregates, and how their formation, toxicity, and spread across specific brain
regions is regulated. Greater understanding of the phospho-tau interactome in AD and primary tauopathies,
and how these proteins regulate the oligomerization, pathological accumulation, and seeding of tau in affected
neurons and glia is of critical importance for the identification of novel therapeutic targets.
 As a limitation of current technologies, the in-depth characterization of NFTs and other neuropathologic
inclusions has historically been difficult to address, since these aggregates are detergent-insoluble, and thus
refractory to classical affinity purification methods. To address this limitation, we have established a novel
method for the proximity-labeling, purification and identification of pathological phospho-tau associated
proteins from fixed human tissue followed by quantitative proteomics analysis.
 We hypothesize that the molecular environment and differential accumulation of pathological tau
aggregates contributes to etiology of AD and related tauopathies. We propose to use the latest cutting-edge
technologies to profile the phospho-tau associated proteome across different patient cohorts and disease
stages, to decipher molecular signaling networks in disease development, and to functionally validate novel
therapeutic targets in mouse models and human organoid systems. Our three specific aims are: (i) to compare
tau pathology-associated proteomes across common tauopathies via proximity proteomics of phospho-tau
inclusions in the brain of AD and primary tauopathy patients, (ii) to establish spatiotemporal patterns of tau
pathology-associated proteomes specific for disease stages in brain regions, and brain resilience in AD patient
cohorts, and (iii) to determine the functional role of tau pathology-associated proteins in neurodegenerative
processes through target validation in AD-related tauopathy mouse models and human brain organoids.
 Successful completion of this project will result in the identification of novel molecular components
regulating tauopathy-specific disease pathways during the pathogenesis of AD and related dementias, which
may provide new therapeutic strate...

## Key facts

- **NIH application ID:** 10763607
- **Project number:** 3RF1AG076122-01A1S1
- **Recipient organization:** MAYO CLINIC  JACKSONVILLE
- **Principal Investigator:** Wilfried Rossoll
- **Activity code:** RF1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $304,220
- **Award type:** 3
- **Project period:** 2022-09-15 → 2025-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10763607

## Citation

> US National Institutes of Health, RePORTER application 10763607, Capturing the molecular complexity of tau pathology-associated proteomes involved in the etiology of Alzheimer's disease and related dementias (3RF1AG076122-01A1S1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10763607. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
